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MaOBJECTIVES The aim of this study was to investigate the extent of diffuse myocardial ﬁbrosis by measuring left (LV)
and right ventricular (RV) extracellular volume fraction (ECV) in patients with repaired tetralogy of Fallot (rTOF) and to
explore its association with ventricular remodeling, hemodynamic load, and clinical parameters.
BACKGROUND Focal myocardial ﬁbrosis is prevalent in patients with rTOF. However, little is known about the extent
of diffuse myocardial ﬁbrosis and its clinical implications in this population.
METHODS Wemeasured ECVby pre- and post-gadoliniumT1measurements using a 1.5-T scanner in 84patientswith rTOF
(median age 23.3 years). LV ECV was determined by averaging values from 6 short-axis mid-ventricular segments, and RV
ECV was calculated by averaging values from the anterior-inferior and the diaphragmatic RV wall segments.
RESULTS LVECV above the upper limit of normal (>28%)was observed in 11 patients and for RVECV (>41%) in9patients.
LVECVcorrelatedpositivelywithRVECV (r¼0.54; p<0.001). Greater RVECVwas associatedwith femalegender, lowerRV
mass-to-volume ratio, lower RV outﬂow tract pressure gradient, and having volume overload as the predominant hemo-
dynamic burden (all p<0.001). Similar associationswere observedwith LV ECV. Inmultivariable analysis, increased LV ECV
was independently associated with arrhythmia, adjusting for age and RV mass index (odds ratio: 5.69; p ¼ 0.031).
CONCLUSIONS In this cohort, LV and RV ECV values were positively correlated, indicating an adverse ventricular-
ventricular interaction at the tissue level. Increased ECV was associated with RV volume overload and arrhythmia. These
ﬁndings may lead to future studies exploring the role of ECV in improving risk stratiﬁcation and guiding therapeutic
interventions. (J Am Coll Cardiol Img 2016;9:1–10) © 2016 by the American College of Cardiology Foundation.A dverse myocardial remodeling in response toan abnormal hemodynamic burden often re-sults in expansion of the extracellular vol-
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ABBR EV I A T I ON S
AND ACRONYMS
CMR = cardiac magnetic
resonance
ECV = extracellular volume
fraction
EDVi = end-diastolic volume
index
EF = ejection fraction
LGE = late gadolinium
enhancement
LV = left ventricle/ventricular
PR = pulmonary regurgitation
rTOF = repaired tetralogy of
Fallot
RV = right ventricle/ventricular
RVOT = right ventricular
outﬂow tract
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2which measures the T1 relaxations times
before and after administration of gadolin-
ium contrast, can determine the myocardial
ECV, a measure of diffuse myocardial ﬁbrosis
(5). Excellent correlation between this tech-
nique and quantitative histopathology in
the left ventricle (LV) has been shown (6),
though it has not been thoroughly examined
in the right ventricle (RV).
In patients with repaired tetralogy of Fallot
(rTOF), adverse ventricular remodeling lead-
ing to severe RV dilation, dysfunction, hy-
pertrophy, and LV dysfunction has been
associated with exercise intolerance, ar-
rhythmias, and late death (7). Previous reports
using late gadolinium enhancement (LGE)
CMR have demonstrated the adverse inter-
action between myocardial LGE and RVfunction, arrhythmias, and exercise tolerance (8).
However, the interaction between myocardial remod-
eling at the tissue level and ventricular mechanics and
clinical parameters is largely unknown. The aims of
this study were to investigate the extent of diffuse
myocardial ﬁbrosis as measured by CMR in patients
with rTOF and to explore the relationships between LV
and RV myocardial ECV and ventricular remodeling,
hemodynamic load, and clinical parameters.SEE PAGE 11METHODS
PATIENTS. We retrospectively searched the database
of the Heart Center at Boston Children’s Hospital from
March 2010 through October 2013 to identify all pa-
tients with rTOF who fulﬁlled the following inclusion
criteria: 1) CMR examination with T1 measurements
and an available hematocrit; 2) 10 to 60 years of age;
3) no cardiovascular intervention within 10 years pre-
ceding the CMR examination except for the initial
repair; and 4) were not taking a medication known to
affect collagen metabolism. The lower age limit co-
incides with routine use of CMR in rTOF patients in our
center, and the upper age limit was selected due to
age-related increased ECV after that age (9). The
Boston Children’s Hospital Committee on Clinical In-
vestigations approved review of the medical records
and waived the requirement for informed consent.
CARDIAC MAGNETIC RESONANCE. CMR examina-
tions were performed using a 1.5-T scanner (Philips
Achieva, Philips Healthcare, Best, the Netherlands).
Biventricular volumes, ejection fractions (EFs), and
ﬂow in the proximal main pulmonary artery were
measured (10). End-diastolic (EDVi) and end-systolicvolume indexes and mass were adjusted to body
surface area. The details of the examination protocol,
measurement technique, and intraobserver, interob-
server, and interstudy variability of these measure-
ments in our laboratory have been reported (10,11).
T1 measurements for ECV calculation were ob-
tained using a previously described Look-Locker
technique (5). An electrocardiography-gated breath-
hold Look-Locker sequence with a segmented
gradient echo cine acquisition was performed at a
single mid-LV short-axis slice (ﬁeld of view 260 mm,
slice thickness 8 mm, voxel size 1.8  1.8  8 mm
reconstructed to 1.01  1.01  8 mm, echo time 2.5 ms,
repetition time 8 ms, ﬂip angle 12, receiver band
width 345 Hz, shot duration 72 ms), once prior to
bolus contrast administration, and 3 times after
contrast. Gadopentetate dimeglumine (Magnevist,
Bayer HealthCare Pharmaceuticals, Wayne, New Jer-
sey) was used for contrast with a bolus dose of 0.15
mmol/kg. Using commercially available software
(QMASS MR, Medis Medical Imaging Systems, Leiden,
the Netherlands), signal intensity versus time curves
were generated from regions of interest in the LV, RV,
and their respective blood pools. In the LV, T1 mea-
surements were performed in a single short-axis
midventricular slice divided by the software into 6
equally spaced sectors. In the RV, the region of in-
terest was located at the anterior-inferior and the
diaphragmatic wall segments (8) (Figure 1).
T1 values were calculated from the signal intensity
versus time curves by ﬁtting to an analytical expres-
sion for the inversion recovery signal intensity
(Figure 1). The myocardial R1 (R1¼1/T1) was plotted
against the blood pool R1. The slope of this relation-
ship deﬁnes the partition coefﬁcient for gadolinium
(l) (12). The myocardial ECV was then computed us-
ing the following equation: ECV ¼ l (1  hematocrit/
100) (5). Values from the 6 LV myocardial segments
were averaged to represent LV ECV, and values for
the anterior-inferior and the diaphragmatic wall seg-
ments were averaged to represent RV ECV. Based on
published reports using the same CMR technique, we
deﬁned an increased LV ECV as >28% (5,13). In
addition, we measured RV ECV values in 20 control
subjects with normal CMR examination (17 were
included in a prior study) (13) to serve as reference
values. Their median age was 16 years (range 11 to
36 years of age) and 55% were male.
LGE imaging was performed 15 min after contrast
administration using a standard 2-dimensional breath-
hold phase-sensitive inversion recovery sequence
with the inversion time selected to null the myocardial
signal (14). RV LGE was graded using a 6-segment
model (8). The extent of segmental LGE was graded
FIGURE 1 Representative Images of T1 Measurements
Right ventricular anterior-inferior segment (arrowhead), diaphragmatic segment (arrow), and blood pool were manually segmented both before (A) and after (B)
administration of gadolinium contrast. The signal intensity versus time curve for each segment was used to determine a segmental T1.
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3according to its linear extent (0 ¼ no LGE; 1 ¼ #2 cm;
2 ¼ 2 to 3 cm; 3 ¼ >3 cm). The superior and inferior
septal-free wall junctions were each scored 0 or 1 ac-
cording to absence or presence of LGE, respectively.ECHOCARDIOGRAPHY. Echocardiograms performed
within 1 year of CMR in patients without in-
terval transcatheter or surgical interventions were
reviewed. The Doppler maximum instantaneous
TABLE 1 Patient Characteristics
All Patients
(n ¼ 84)
Volume Overload
(n ¼ 45)
Mixed Volume/Pressure Load
(n ¼ 39) p Value
Age at CMR, yrs 23.3 (16.3–32.8) 21.9 (15.5–36.1) 23.5 (17.2–32.2) 0.975
Male 47 (56.0) 24 (53.3) 23 (59.0) 0.603
Age at repair, yrs 0.9 (0.4–4) 0.8 (0.5–6.1) 0.7 (0.3–3.7) 0.248
Time from repair to CMR, yrs 20.4 (14.6–28.2) 21.3 (14.1–33.7) 20.3 (15.7–27.2) 0.717
Diagnosis 0.086
TOF/pulmonary stenosis 63 (75.0) 38 (84.4) 25 (64.1)
TOF/pulmonary atresia 19 (22.6) 6 (13.3) 13 (33.3)
TOF/AV canal 2 (2.4) 1 (2.2) 1 (2.6)
Type of repair (n ¼ 83) <0.001
Transannular patch 50 (60.2) 31 (70.5) 19 (48.7) 0.043
RV-PA conduit 20 (24.1) 4 (9.1) 16 (41.0) 0.001
Nontransannular RVOT patch 10 (12.0) 9 (20.5) 1 (2.6) 0.016
QRS duration, ms 140  32 142  30 137  34 0.487
Peak RVOT pressure gradient, mm Hg 20.0 (15.0–32.0) 16.5 (10.0–20.0) 39.0 (20.0–51.3) <0.001
Peak VO2, ml/min/kg 26.5  7.2 27.2  8.0 25.6  6.1 0.397
% Predicted peak VO2 72.0  15.0 73.7  15.7 70.0  14.1 0.351
CMR data
RV EDVi, ml/m2 153.8  47.8 168.7  43.0 136.7  47.8 0.002
RV ESVi, ml/m2 83.3  39.6 89.1  30.3 76.7  47.7 0.152
RVEF, % 47.4  9.5 48.1  6.5 46.6  12.1 0.489
RV mass index, g/m2 31.1  9.3 30.3  7.5 32.0  11.1 0.408
RV mass-to-volume ratio, g/ml 0.20 (0.17–0.24) 0.18 (0.15–0.20) 0.22 (0.20–0.27) <0.001
RV extracellular volume fraction, % 34.2  5.6 36.0  5.3 31.8  5.0 <0.001
RV LGE score 4.0 (3.0–5.0) 4.0 (3.0–4.8) 4.0 (2.8–5.0) 0.548
PR fraction, % 36.7  15.4 45.6  9.6 26.4  14.6 <0.001
LV EDVi, ml/m2 89.3  17.6 89.6  19.5 89.0  15.3 0.864
LV ESVi, ml/m2 41.2  11.3 39.6  10.7 42.9  11.8 0.178
LVEF, % 54.2  7.3 56.0  4.8 52.1  9.0 0.021
LV mass index, g/m2 50.3  9.8 50.5  10.4 49.9  9.1 0.776
LV mass-to-volume ratio, g/ml 0.55 (0.49–0.63) 0.55 (0.50–0.64) 0.55 (0.48–0.63) 0.812
LV extracellular volume fraction, % 24.3  3.3 24.9  3.1 23.5  3.4 0.057
Arrhythmia* 25 (29.8) 15 (33.3) 10 (25.6) 0.441
Frequent ventricular ectopy 11 6 5
Nonsustained VT 2 1 1
Sustained VT 1 1 0
Supraventricular tachycardia 12 7 5
Atrial ﬂutter 7 4 3
Atrial ﬁbrillation 1 1 0
Exercise intolerance (n ¼ 54) 29 (53.7) 16 (53.3) 13 (54.2) 0.795
Values are median (interquartile range), n (%), or mean  SD. *Nine patients had more than 1 type of arrhythmia.
AV ¼ atrioventricular; CMR ¼ cardiac magnetic resonance; EDVi ¼ end-diastolic volume index; EF ¼ ejection fraction; ESVi ¼ end-systolic volume index; LGE ¼ late gad-
olinium enhancement; LV ¼ left ventricular; PR ¼ pulmonary regurgitation; RV ¼ right ventricular; RV-PA ¼ right ventricular-to-pulmonary artery; RVOT ¼ right ventricular
outﬂow tract; TOF ¼ tetralogy of Fallot; VO2 ¼ oxygen consumption; VT ¼ ventricular tachycardia.
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4pressure gradient across the right ventricular outﬂow
tract (RVOT) was recorded.
EXERCISE DATA. Cardiopulmonary exercise tests
were performed on a bicycle ergometer using a ramp
wise increase of load. Analysis of expiratory gases
was performed using a metabolic cart (Medical
Graphics Corporation, St. Paul, Minnesota). Peak ox-
ygen consumption was measured and expressed as
the percentage of predicted values for age and
gender.CLASSIFICATION OF HEMODYNAMIC LOAD. Patients
were classiﬁed into 1 of the following 3 groups based
on their predominant hemodynamic load: 1) volume
overload (pulmonary regurgitation [PR] fraction$25%
and peak RVOT gradient #25 mm Hg); 2) pressure
overload (PR fraction <25% and RVOT gradient $40
mm Hg); and 3) mixed volume and pressure load
(all remaining patients).
ARRHYTHMIA AND EXERCISE ENDPOINTS. Arrhythmia
was deﬁned as atrial or ventricular arrhythmias
FIGURE 2 Relationship Between LV ECV and RV ECV
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FIGURE 3 ECV and Type of Hemodynamic Load
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5documented by a 24-h Holter monitor or other
electrocardiography recording. Atrial arrhythmias
included supraventricular tachycardia, atrial ﬁbril-
lation, or atrial ﬂutter. Ventricular arrhythmia
included frequent ventricular ectopy (>100 prema-
ture ventricular contractions or >20 couplets per
24 h), nonsustained ventricular tachycardia <30 s,
and sustained ventricular tachycardia lasting $30 s
(7). Exercise intolerance was deﬁned as percent
predicted peak oxygen consumption #70% for age
and gender (15).
STATISTICAL ANALYSIS. Variables were summa-
rized as mean  SD, median and interquartile range,
or numbers and percentages, as appropriate. Com-
parisons between groups were performed using
independent-samples t test or Mann-Whitney U test
and within groups using Wilcoxon signed rank test
with Bonferroni correction, respectively. Categorical
variables were compared using the chi-square or the
Fisher exact test, as appropriate. Correlations be-
tween continuous variables were explored with a
Pearson correlation coefﬁcient. Univariable factors
related to arrhythmia and exercise endpoints at p <
0.05 were included in multivariable stepwise logistic
regression analysis, and a Nagelkerke’s R2 was re-
ported for the ﬁnal model. Intraobserver and inter-
observer variability of ECV measurements were
determined in 15 randomly selected patients using
intraclass correlation coefﬁcient. Analyses were per-
formed using SPSS version 19.0 (SPSS Inc., Chicago,
Illinois). A 2-sided p value <0.05 was considered
statistically signiﬁcant.
RESULTS
PATIENTS. Table 1 summarizes the demographic,
anatomic, surgical, CMR, Doppler, and arrhythmia
and exercise endpoints of the 84 patients who met
inclusion criteria. The median age at CMR was 23.3
years and 56% were males. The median age at TOF
repair was 0.9 years with a median interval between
repair and CMR of 20.4 years.
LV AND RV ECV. The mean LV ECV was 24.3  3.3%
(range 16.7% to 32.7%); 11 patients (13.1%) had an
increased LV ECV (>28%). The mean RV ECV was 34.2
 5.6% (range 20.7% to 47.4%), which was signiﬁ-
cantly higher than the LV ECV (p < 0.001). In control
subjects, the mean RV ECV value was 28.4  6.3%,
which was signiﬁcantly lower than that in rTOF pa-
tients (p < 0.001). Using 2 standard deviations above
the mean control ECV as the upper limit of normal
(41%), 9 patients (10.7%) had an increased RV ECV.
In patients with rTOF, LV and RV ECV were posi-
tively and linearly correlated (r ¼ 0.541, p < 0.001)(Figure 2). In addition, both RV ECV (36.8  5.8% vs.
32.2  4.5%; p < 0.001) and LV ECV (25.2  3.0% vs.
23.5  3.4%; p ¼ 0.017) were higher in females
compared with males. Neither anatomic diagnosis nor
age at repair was associated with LV or RV ECV.
ECV AND TYPE OF HEMODYNAMIC LOAD. Based on
the pre-deﬁned criteria, 45 patients had RV volume
overload, 5 had RV pressure overload, and 34 had
FIGURE 4 Relationship Between RV ECV and RVOT Doppler Gradient
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6mixed volume and pressure load. Comparisons of
demographic, anatomic, surgical, and CMR data
found no signiﬁcant differences between the pressure
overload and the mixed load groups. Consequently,
the groups were combined and the comparison be-
tween them is shown in Table 1. The prevalence of a
conduit between the RV and the pulmonary arteries
was signiﬁcantly higher in the patients with mixedship Between RV ECV and RV Mass-to-Volume Ratio
r = -0.396
p < 0.001
RV ECV (%)
25 30 35 40 45 50
n right ventricular (RV) extracellular volume fraction (ECV) and RV
o.load as compared with the volume overload group
(41% vs. 9%, p ¼ 0.001). PR fraction and RV EDVi were
signiﬁcantly higher in the volume overload group as
compared with the mixed load and the peak Doppler
gradient across the RVOT and RV mass-to-volume
ratio were signiﬁcantly lower (Table 1). The groups
did not signiﬁcantly differ in RV end-systolic volume
index, EF, and mass index.
Notable differences in myocardial ECV were
observed between the types of hemodynamic load
(Figure 3). Speciﬁcally, patients with volume overload
had signiﬁcantly greater RV ECV than those with
mixed load (36.3  5.3% vs. 31.8  5.0%; p < 0.001)
(Table 1). Moreover, analysis of the entire cohort
found that RV ECV was inversely related to the peak
RVOT Doppler gradient (r ¼ –0.477, p < 0.001)
(Figure 4), RV mass-to-volume ratio (r ¼ –0.396, p <
0.001) (Figure 5), and RV mass index (r ¼ –0.254, p ¼
0.020). In the subgroup of patients with severe RV
hypertrophy (RV mass-to-volume ratio $0.28, n ¼ 11),
RV ECV tended to be higher in those with RV
dysfunction (EF <45%) as compared with those with
RVEF $45% (36.2  6.9% vs. 28.1  6.9%, p ¼ 0.082).
In the LV, patients with volume overload tended to
have greater ECV than those with mixed load (24.9 
3.1% vs. 23.5  3.4%; p ¼ 0.057) and those with
pressure overload (24.9  3.1% vs. 20.9  3.0%, p ¼
0.016). LV ECV was inversely correlated with RVOT
Doppler gradient (r ¼ –0.356, p ¼ 0.003), and LV mass-
to-volume ratio (r ¼ –0.239, p ¼ 0.029).
LATE GADOLINIUM ENHANCEMENT. LGE was pre-
sent in 94% of the patients, most commonly in the
RVOT (87%) and in the inferior septal-free wall
junction (81%). LGE was noted in the anterior-inferior
free wall in 2 patients and care was taken to exclude
these areas from ECV calculations. None had LGE in
the diaphragmatic RV wall. RV LGE score was not
associated with RV ECV. Only 4 patients had focal
LGE at the LV apex.
ECV AND ARRHYTHMIA AND EXERCISE PARAMETERS.
Arrhythmias were documented in 25 patients (30%)
and their types are detailed in Table 1. Table 2 sum-
marizes the likelihood of clinical, CMR, and other
parameters to be associated with arrhythmia by uni-
variable analysis. Compared with patients free of
arrhythmia, those with arrhythmia had a higher LV
ECV (25.4  3.4% vs. 23.8  3.1%; p ¼ 0.039) and a
higher proportion of them had increased LV ECV (28%
vs. 7%; p ¼ 0.014). RV ECV was similar in patients
with and without arrhythmia. Other parameters
associated with arrhythmia included older age at
repair and at CMR, longer QRS duration, higher RV
EDVi and mass index, and higher LV mass index.
TABLE 2 Univariable Factors Associated With Arrhythmia and Exercise Intolerance
Units Odds Ratio 95% CI p Value C statistic
Arrhythmia
LV ECV, % [1 1.165 1.004–1.351 0.044 0.631
Increased LV ECV >28% 5.347 1.402–20.397 0.014 0.606
RV ECV, % [1 1.004 0.923–1.092 0.927 0.503
Age at CMR, yrs [5 1.534 1.205–1.952 0.001 0.748
Sex Male 1.266 0.489–3.273 0.627 0.529
Age at repair, yrs [1 1.089 1.038–1.143 0.001 0.684
QRS duration, ms [10 1.232 1.037–1.464 0.017 0.665
RV EDVi, ml/m2 [5 1.068 1.012–1.127 0.018 0.614
RV ESVi, ml/m2 [5 1.084 1.010–1.164 0.025 0.635
RVEF, % [5 0.824 0.642–1.058 0.128 0.594
RV mass index, g/m2 [10 1.997 1.096–3.636 0.024 0.653
RV mass-to-volume ratio, g/ml [0.1 0.928 0.406–2.125 0.928 0.491
PR fraction, % [10 1.101 0.807–1.502 0.544 0.522
RV LGE score [1 1.343 0.978–1.845 0.069 0.622
LV EDVi, ml/m2 [5 1.147 0.999–1.317 0.052 0.602
LV ESVi, ml/m2 [5 1.249 1.009–1.546 0.041 0.639
LVEF, % [5 0.821 0.596–1.130 0.226 0.573
LV mass index, g/m2 [10 1.541 0.935–2.537 0.090 0.585
Exercise intolerance
LV ECV, % [1 1.028 0.877–1.207 0.730 0.527
Increased LV ECV >28% 1.528 0.326–7.154 0.591 0.526
RV ECV, % [1 0.949 0.861–1.046 0.291 0.582
Age at CMR, yrs [5 1.460 1.076–1.980 0.015 0.727
Sex Male 2.051 0.675–6.231 0.205 0.585
Age at repair, yrs [1 1.079 1.015–1.146 0.015 0.636
QRS duration, ms [10 1.404 1.105–1.784 0.006 0.746
RV EDVi, ml/m2 [5 1.074 0.991–1.164 0.084 0.639
RV ESVi, ml/m2 [5 1.138 1.008–1.286 0.036 0.687
RVEF, % [5 0.700 0.506–0.968 0.031 0.673
RV mass index, g/m2 [10 2.212 1.002–4.882 0.049 0.659
RV mass-to-volume ratio, g/ml [0.1 1.475 0.598–3.639 0.399 0.523
PR fraction, % [10 0.979 0.684–1.402 0.907 0.533
LV EDVi, ml/m2 [5 1.069 0.911–1.253 0.413 0.514
LV ESVi, ml/m2 [5 1.275 0.974–1.668 0.077 0.659
LVEF, % [5 0.672 0.443–1.021 0.063 0.688
LV mass index, g/m2 [10 1.132 0.759–2.270 0.331 0.559
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
TABLE 3 Multivariable Analysis of Factors Associated With Arrhythmia
and Exercise Intolerance
Outcomes Predictors
Odds
Ratio 95% CI p Value Model R2
Arrhythmias Age (per [5 yrs) 1.63 1.23–2.15 0.001 0.398
RV mass index (per [10 g/m2) 2.44 1.19–5.01 0.015
Increased LV ECV (>28%) 5.69 1.17–27.59 0.031
Exercise intolerance Age (per [5 yrs) 1.73 1.15–2.61 0.008 0.442
RV mass index (per [10 g/m2) 3.66 1.23–10.92 0.020
QRS duration (per [10 ms) 1.35 1.02–1.79 0.037
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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7Multivariable analysis identiﬁed abnormally in-
creased LV ECV (>28%) as independently associated
with arrhythmia (odds ratio: 5.69, 95% conﬁdence
interval: 1.17 to 27.59; p ¼ 0.031), after adjusting for
age and RV mass index (Table 3).
Exercise data were available in 62 patients, and 8
were excluded from the analysis due to submaximal
effort (peak respiratory exchange ratio <1.1). The
median time interval between cardiopulmonary ex-
ercise testing and CMR was 1 month (range 0 to 22.9
months). Exercise intolerance was noted in 29 pa-
tients (54%). LV and RV ECV did not differ between
patients with and without exercise intolerance and
did not correlate with exercise parameters. Uni-
variable and multivariable correlates of exercise
intolerance are shown in Tables 2 and 3, respectively.
REPRODUCIBILITY. Intraobserver and interobserver
variability for LV and RV ECV calculations was good.
The intraclass correlations, mean difference between
measurements, and the ratio of absolute difference to
the mean of 2 measurements are shown in Table 4.
DISCUSSION
This is the ﬁrst study to examine the associations be-
tween LV and RV ECV, the type of hemodynamic load,
and arrhythmia and exercise parameters in patients
with rTOF. We found that LV and RV ECV correlate
positively with each other and that a greater ECV is
associated with RV volume overload as opposed to
pressure overload or mixed load. Furthermore, a LV
ECV above the upper limit of normal (>28%) was
independently associated with arrhythmias. These
ﬁndings provide new insights into myocardial
remodeling at the tissue level in patients with rTOF.
Only 2 previous studies evaluated CMR measures
of diffuse myocardial ﬁbrosis in rTOF. Broberg et al.
(5) included 17 patients with rTOF among a larger
series of adult patients with congenital heart disease.
Similar to our ﬁnding, the extent of LGE did not
correlate with LV ECV. However, Broberg et al. (5) did
not evaluate the subpulmonary RV. The other study
was by Kozak et al. (16) and reported T1 values after
contrast administration in 18 children with rTOF.
Although ECV measurements could not be pre-
formed due to absent pre-contrast T1 measurements
and hematocrit values, Kozak et al. (16) found shorter
T1 values in the LV and RV of rTOF patients as
compared with control subjects. Notably, both of
these studies (5,16) lacked the statistical power to
explore associations with different types of hemo-
dynamic loads and with clinical outcomes.
Studies in patients with rTOF have shown
distinctly different patterns of RV remodeling at the
TABLE 4 Observer Variability for ECV
Intraobserver Interobserver
Ratio of Absolute
Difference to Mean
(95% CI)
Mean Difference
(95% CI) p Value
ICC
(95% CI)
Ratio of Absolute
Difference to Mean
(95% CI)
Mean Difference
(95% CI) p Value
ICC
(95% CI)
LV ECV, % 0.036
(0.021 to 0.052)
0.287
(–0.326 to 0.900)
0.332 0.95
(0.86 to 0.98)
0.028
(0.014 to 0.043)
–0.270
(–0.802 to 0.262)
0.294 0.95
(0.86 to 0.98)
RV ECV, % 0.050
(0.019 to 0.080)
–0.415
(–1.779 to 0.950)
0.525 0.93
(0.80 to 0.98)
0.075
(0.040 to 0.110)
–1.871
(–3.415 to –0.328)
0.021 0.91
(0.74 to 0.97)
CI ¼ conﬁdence interval; ICC ¼ intraclass correlation coefﬁcient; other abbreviations as in Table 1.
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8chamber level depending on the type of hemody-
namic load (17). However, assessment of myocardial
remodeling at the tissue level was hampered by lack
of noninvasive techniques capable of differentiating
between cardiomyocytes and the interstitial com-
partment. Using CMR T1 measurements, our ﬁndings
suggested that increase in the relative volume of the
extracellular matrix with a concomitant loss of car-
diomyocytes might characterize the myocardium of
patients with high RV ECV values, which was most
prominent in those with volume overload. Because
ECV reﬂects the ratio of extracellular matrix volume
to total myocardial volume (extracellular matrix vol-
ume plus cardiomyocytes volume), increased ECV
indicates either that expansion of the extracellular
matrix exceeds cardiomyocytes hypertrophy, or car-
diomyocytes atrophy/death while the extracellular
matrix component becomes proportionally larger.
The ﬁrst scenario should have resulted in a positive
relationship between ECV and mass-to-volume ratio.
As RV ECV was negatively related to RV mass-to-
volume ratio, myocyte loss or adaptive atrophy is a
plausible mechanism of cellular remodeling in pa-
tients with low RV mass-to-volume ratio, which is a
marker of failed compensatory eccentric hypertrophy
to maintain normal wall stress (10). This hypothesis is
supported by the ﬁndings of Misaki et al. (18), who
observed that myocardial degeneration, myocyte islet
formation, adiposis, and ﬁbrosis were found in RV
tissue specimens from rTOF patients with unob-
structed RVOT. It is therefore reasonable to speculate
that in rTOF patients with volume overload, the
combination of decreasing RV mass-to-volume ratio
and increasing RV ECV is consistent with a maladap-
tive process at the cellular level characterized by
cardiomyocyte atrophy and diffuse ﬁbrosis.
The phenomenon of RV-LV interdependence has
been documented in rTOF as well as other congenital
and acquired heart diseases (19,20). It has been
attributed to several coupling mechanisms, including
abnormal septal motion and ventricular dyssyn-
chrony (19,20). In addition to the known adverseinteractions between biventricular volumes and EFs
(17,19), our results show, for the ﬁrst time, a positive
relationship between RV and LV at the tissue level in
terms of diffuse myocardial ﬁbrosis. In addition, we
found that similar to the RV, an inverse correlation
between LV ECV and LV mass-to-volume ratio was
present. Although histopathologic evidence showing
loss or atrophy of LV cardiomyocytes in rTOF has not
been documented, studies in other conditions pro-
vide supportive evidence. For example, in chronic
thromboembolic pulmonary hypertension, RV failure
is associated with reduction in LV free wall mass and
cardiomyocyte atrophy (21). It is conceivable that
adverse ventricular-ventricular interaction in rTOF
leads to underﬁlling of the LV with subsequent atro-
phic remodeling (22).
The results of this investigation have several po-
tential clinical implications in terms of prognosis,
therapy, and indications for RVOT interventions after
initial repair. Evidence suggests that diffuse myocar-
dial ﬁbrosis is a key element of the maladaptive
response to chronic hemodynamic overload and its
onset likely precedes frank ventricular dysfunction.
Given the continued uncertainty regarding our ability
to accurately determine when patients approach
irreversible myocardial damage, it is tempting to
speculate that noninvasive surveillance and early
detection of diffuse myocardial ﬁbrosis may lead to
more timely interventions aimed at ameliorating the
abnormal hemodynamic load and allowing full re-
covery of cardiac function. Another potential avenue
for therapy in this group of patients is antiﬁbrotic
therapy that may slow down the maladaptive process
(23). Finally, additional research is warranted to
investigate whether measurements of diffuse ﬁbrosis
by CMR improve our ability to predict adverse clinical
outcomes in patients with rTOF.
STUDY LIMITATIONS. This cohort does not repre-
sent the entire spectrum of patients with rTOF as
patients with pacemakers and implantable de-
ﬁbrillators were excluded. The normal RV and LV
ECV data in our study was derived from a relatively
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Among young
adult patients with repaired TOF, this CMR study with ECV
measurements in the LV and RV demonstrates positive linear
correlation between RV and LV ECV, indicating adverse
ventricular-ventricular interaction at the tissue level. Further-
more, RV ECV fraction is associated with the type of abnormal
hemodynamic load (volume versus pressure) and greater LV ECV
is associated with arrhythmias.
TRANSLATIONAL OUTLOOK: Further studies are required to
reﬁne and validate the ECV measurement technique, especially in
the RV, and to establish robust age- and gender-speciﬁc
normative values for both ventricles in a large population. The
ﬁndings of this study may stimulate further research to explore
the role of ECV in reﬁning risk stratiﬁcation and guiding thera-
peutic interventions in patients with rTOF.
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9small cohort. Further studies are required to
establish age- and gender-speciﬁc normative values
for both ventricles in a larger population. Although
particular care was taken to demarcate the thin-
walled compact RV myocardium, partial volume
effects and contamination of the T1 values from the
inclusion of blood or epicardial fat in the region of
interest remain potential pitfalls with the current
CMR technique and may result in artiﬁcially high
RV ECV values. Other notable limitations include
the retrospective study design, lack of histology
correlation, and a small number of subjects with
pure RV pressure overload. Finally, although we
have demonstrated an association between ECV and
arrhythmias, further study using stronger endpoints
such as sustained ventricular tachycardia and death
is warranted.
CONCLUSIONS
We found a positive linear relationship between LV
and RV ECV, implying an adverse ventricular-
ventricular interaction at the tissue level in rTOF.
For both ventricles, higher ECVs were associated with
lower ventricular mass-to-volume ratio, lower RVOT
pressure gradient, and RV volume overload. Further-
more, increased LV ECV was independently associ-
ated with arrhythmias. In addition to providing new
insights into the role of diffuse ﬁbrosis in ventricular
remodeling and arrhythmias, these ﬁndings may lead
to future studies to explore the role of ECV in
improving risk stratiﬁcation and to guide therapeutic
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